Read more on MIMS Pharma To view or add a comment, sign in Roquette expands cyclodextrin innovation with new dual-route excipient Roquette has launched KLEPTOSE Crysmeb, a novel methyl-beta-cyclodextrin (MCD) engineered to boost solubility, stability and bioavailability across a wide range of APIs
Farazi Frontiers in Nutrition .2026;[Epub] CrossRef Providing holistic care for patients with metabolic dysfunctionassociated steatotic liver disease/metabolic dysfunctionassociated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and inter Lanlan Chen, Paul Horn, Frank Tacke Diabetes, Obesity and Metabolism .2026
No published clinical trial appears to evaluate GLPro as a finished proprietary formula
Ozempic is the manufacturers FDA-approved semaglutide sold at retail
Gim vim v h tr hi phc: Truyn vitamin C gip gim phn ng vim ton thn v thc y lnh vt thng [6]
Protein is another big one